Accueil

Valneva completes recruitment for Phase 3 Lot-to-Lot Consistency Trial of its Chikungunya Vaccine Candidate

Latest Posts

iSRS 2022 International Symposium on Radiopharmaceutical Sciences | A gathering of world-renowned experts in radiopharmaceutical sciences in Nantes

22 April 2022

From 29th May to 2nd June 2022, around 400 researchers from the world over will gather at the Cité des... View Article

Valneva receives conditional marketing authorization from UK MHRA for its inactivated COVID-19 vaccine

14 April 2022

Valneva, a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom... View Article

Transplantation & immunology | Parean Biotechnologies joins a European consortium funded by Horizon Europe

1 April 2022

Parean Biotechnologies is officially partner and consortium member, of Horus Project ! This new approved 7+ Million Euros project, funded by... View Article

« Previous 1 … 20 21 22 23 24 … 160 Next »